Endoret PRGF – Revolutionizing
Dry Eye Syndrome Treatment

Endoret PRGF (Plasma Rich in Growth Factors) is changing the treatment landscape for Dry Eye Syndrome, offering renewed hope to sufferers.

According to the CNIB, approximately 30% of Canadians are affected by dry eye syndrome causing discomfort, blurred vision, and even vision impairment. Traditional dry eye treatments offer some relief, but sufferers want a lasting solution. Endoret may be the breakthrough therapy they’ve been waiting for.

In this post, our Markham eye doctors explain:

• The development of Endoret PRGF
• How PRGF works
• Success rates
• Regulatory approval
• And patient experience of Endoret therapy

Find Out If Endoret Therapy Is Right for You
Call us at 1-905-477-4488

Endoret Development

Endoret PRGF therapy is a form of regenerative medicine that leverages your body’s natural healing processes to address dry eye syndrome. Endoret was developed by the pioneering research of Dr. Eduardo Anitua in Spain. This innovative approach harnesses the power of platelet-rich plasma to promote tissue regeneration and alleviate symptoms associated with dry eyes.

How Endoret Therapy Works

The therapy involves a simple yet sophisticated process. A small sample of the patient’s blood is drawn and centrifuged. The centrifugal force separates the plasma containing concentrated platelets and growth factors. This platelet rich Endoret plasma, enriched with healing compounds, is then administered directly to the affected eye(s) of the patient. Once introduced, the growth factors in the PRGF stimulate tissue repair, reduce inflammation, and improve overall ocular health.

Success Rates & Efficacy

The effectiveness of Endoret PRGF therapy in treating dry eye conditions is well-documented, with numerous clinical studies showcasing its effectiveness. A landmark study was published in the Journal of Ophthalmology. Researchers found that Endoret significantly improved both subjective and objective measures of dry eye syndrome, including tear film stability and ocular surface health. Dry eye patients also reported a notable reduction in dry eye symptoms, irritation, and visual problems.

Statistics from various clinical trials reveal impressive success rates as well. A significant percentage of patients experienced substantial relief from dry eye symptoms following Endoret treatment. These findings underscore the potential of this therapy as a viable alternative or complement to traditional approaches to dry eye treatment.

Regulatory Approval & Adoption

Endoret therapy has garnered recognition and approval from regulatory bodies worldwide for its safety and efficacy in treating dry eye syndrome. While specific approvals may vary by region, Endoret PRGF has gained traction in several countries, including United States, Spain, and parts of Europe.

Health Canada has approved PRGF and platelet-rich plasma for use in the promotion of wound healing. The growing reputation and promising results have prompted increased interest from healthcare professionals and dry eye patients alike. Endoret PRGF is a valuable addition for medical professionals in the treatment of dry eye syndrome in Canada.

Patient Experience & Expectations

For individuals suffering from dry eyes, Endoret therapy offers newfound hope for relief and improved quality of life. Patients who undergo Endoret treatment at our Markham dry eye clinic can expect a straightforward and minimally invasive procedure. The treatment is performed under the supervision of our qualified ophthalmologist.

During the treatment session, patients may experience mild discomfort or a sensation of pressure as the PRGF solution is applied to the eye(s). However, these sensations are temporary and generally well-tolerated. Following the procedure, you can resume your daily activities with minimal downtime. Minor side effects may include temporary redness or sensitivity.

In the weeks following Endoret treatment, our patients often notice a gradual improvement in their dry eye symptoms as the regenerative effects of the Endoret PRGF therapy take hold. Many patients report a reduction in dryness, irritation, and visual issues, accompanied by an overall improvement in ocular comfort and function. While individual responses may vary, many of our patients experience significant relief and long-lasting benefits from Endoret PRGF treatment.

Is Endoret Therapy Right for You?

Endoret PRGF therapy is a ground-breaking advancement in the management of Dry Eye Syndrome. It offers a safe, effective, and minimally invasive solution for dry eye patients who want relief from this debilitating condition.

With its proven success rates, regulatory approval, and positive patient outcomes, Endoret is a promising transformative therapy available to patients in our dry eye clinic. Our optometrists would first perform a comprehensive evaluation to assess your eye health and determine the appropriate treatment.

Contact Unionville Optometry in Markham ON

If you suffer from dry eye syndrome and are interested in this innovative treatment, visit our dry eye clinic.

Contact our eye doctors at Unionville Optometry to learn more about Endoret PRGF dry eye treatment or to book an appointment with our optometrists Dr. David Innamorato or Dr. Krista Innamorato.

We can also be reached by calling 1-905-477-4488.

Endoret FAQs

What is Endoret PRGF Therapy?

Endoret therapy, also known as Plasma Rich in Growth Factors, is a cutting-edge regenerative medicine approach used to treat various medical conditions, including Dry Eye Syndrome.

How does Endoret PRGF Therapy work?

With Endoret therapy, a small sample of the patient’s blood is taken and centrifuged to separate the plasma containing concentrated platelets and growth factors. This platelet-rich plasma is then applied directly to the patient’s affected eye(s). The growth factors present in the PRGF stimulate tissue repair, reduce inflammation, and promote overall ocular health.

Is Endoret PRGF Therapy safe?

Yes, Endoret therapy is considered safe when performed by qualified healthcare professionals in a clinical setting. Since the therapy utilizes the patient’s own blood components, there is minimal risk of adverse reactions or rejection. Additionally, stringent protocols are followed to ensure the sterility and quality of the PRGF solution, further minimizing any potential risks.

How long does an Endoret PRGF treatment session take?

An Endoret PRGF treatment session typically takes around 30 to 60 minutes, including preparation and administration. The procedure itself is relatively quick and minimally invasive.

How many Endoret PRGF sessions are required to see results?

The number of Endoret therapy sessions required can vary depending on the severity of the Dry Eye Syndrome and individual patient response. In many cases, patients experience significant improvement after just one or two treatment sessions. However, a personalized treatment plan may involve multiple sessions spaced out over several weeks to achieve optimal results.

What can I expect during and after an Endoret PRGF treatment session?

During an Endoret therapy session, dry eye patients may experience mild discomfort or a sensation of pressure as the PRGF solution is applied to the eye(s). However, these sensations are temporary and generally well-tolerated. After the procedure, patients may experience minor side effects such as temporary redness or sensitivity, but these typically subside within a few days. Over time, patients often notice a gradual improvement as the regenerative effects of the therapy take hold.

How long do the effects of Endoret PRGF therapy last?

The duration of the effects of Endoret therapy can vary depending on individual factors such as the severity of dry eye syndrome and the patient’s overall eye health. While some patients may experience long-lasting relief from symptoms, others may require periodic maintenance treatments to sustain the benefits. A comprehensive evaluation by an ophthalmologist can help determine the appropriate treatment frequency and duration for each patient.

Is Endoret PRGF therapy covered by insurance?

Coverage for Endoret therapy may vary depending on the patient’s insurance provider and policy. Patients are encouraged to check with their insurance provider to determine their specific coverage options.

Who is a suitable candidate for Endoret PRGF therapy for Dry Eye Syndrome?

Endoret therapy may be suitable for persons diagnosed with Dry Eye Syndrome who have not responded adequately to conventional dry eye treatments such as artificial tears or medications. Candidates for this therapy need to undergo a thorough evaluation by a qualified ophthalmologist to assess their eligibility and determine the most appropriate treatment approach.